Sign In |Help & Support
HOMECHINA STANDARDSICS CLASSIFICATIONINDUSTRY CLASSIFICATIONCHINESE CLASSIFICATIONCART(0)
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)
  1. HOME
  2. Standards for Cell Therapy Class III

Cell Therapy Class III

Cell Therapy Class III, Total:63 items.

The international standard classification for "Cell Therapy Class III" includes: Biology. Botany. Zoology .

The Chinese standard classification for "Cell Therapy Class III" includes: Pharmaceutical in general .

Professional Standard - Agriculture

Shanghai Provincial Standard of the People's Republic of China

  • DB31/T 687-2013 Basic requirements for clinical cell therapy platform settings

Hebei Provincial Standard of the People's Republic of China

  • DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy

Group Standards of the People's Republic of China

  • T/SDHCST 006-2023 Procedures for Single Dose Toxicity Testing of the Cell Therapy Medical Products
  • T/CHSA 004-2022 Expert consensus on surgical treatment of squamous cell carcinoma of tongue mucosa
  • T/SDHCST 007-2023 Procedures for Repeated Dose Toxicity Testing of the Cell Therapy Medical Products
  • T/CAV 008-2024 Basic functional specification for cell therapy product traceability management information system
  • T/CMBA 021-2023 Specification of quality management for ancillary materials present during the production of cellular therapeutic products
  • T/SDHCST 005-2023 Procedures for Safety Pharmacology Testing of the Cell Therapy Medical Products
  • T/CGCPU 027-2023 Design specifications for clinical research protocol of immunotherapy
  • T/CI 307-2024 Quality requirements of mesenchymal stem cells for therapy
  • T/SDHCST 002-2023 Test Substance Requirements on the Non-Clinical Studies of the Cell Therapy Medical Products
  • T/SHPPA 021-2023 Import and export management guidance for CAR-T cell therapy products and their materials
  • T/SHQAP 003-2023 Guidelines for application of space separative closed systems for cell therapies production
  • T/SDHCST 001-2023 General Principles on the Non-Clinical Studies of the Cell Therapy Medical Products
  • T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products

农业农村部

Professional Standard - Aquaculture

American Society for Testing and Materials (ASTM)

  • ASTM F3368-19 Standard Guide for Cell Potency Assays for Cell Therapy and Tissue Engineered Products

KR-KS

  • KS P 1600-2018(2023) General guideline of safety test for the cell based therapeutic substances
  • KS J ISO 21973-2023 Biotechnology — General requirements for transportation of cells for therapeutic use

Korean Agency for Technology and Standards (KATS)

  • KS P 1600-2023 General guideline of safety test for the cell based therapeutic substances
  • KS P 1600-2007 General guideline of safety test for the cell based therapeutic substances

IT-UNI

  • UNI ISO 21973:2021 Biotechnology - General requirements for transportation of cells for therapeutic use

International Organization for Standardization (ISO)

  • ISO 21973:2020 Biotechnology — General requirements for transportation of cells for therapeutic use
  • ISO 20399:2022 Biotechnology — Ancillary materials present during the production of cellular therapeutic products and gene therapy products

SCC

  • DANSK DS/ISO 21973:2020 Biotechnology – General requirements for transportation of cells for therapeutic use
  • BS PAS 83:2006 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics
  • DANSK DS/ISO 20399:2022 Biotechnology – Ancillary materials present during the production of cellular therapeutic products and gene therapy products

GOST

  • GOST R ISO 21973-2023 Biotechnology. General requirements for transportation of cells for therapeutic use

British Standards Institution (BSI)

  • BS ISO 21973:2020 Biotechnology. General requirements for transportation of cells for therapeutic use
  • BS ISO 20399:2022 Biotechnology. Ancillary materials present during the production of cellular therapeutic products and gene therapy products
  • 19/30354962 DC BS ISO 21973. Biotechnology. General requirements for transportation of cells for therapeutic use

cell therapy,cell therapy,Primary Cell Therapy,cell therapy standards and,therapeutic cells,cell therapy,Cell Therapy Laboratory,Cell Therapy Laboratory,Cell Therapy Class III,cell therapy group,Boost Cell Therapy,Cell Therapy Thirteenth Five-Year Plan,Cell Therapy Safety,Cell Therapy Two,where is cell therapy,where cell therapy,Cell Therapy Laboratory,gene therapy target cells

All Rights Reserved © 2026 WWW.CHINASTANDARDS.NET visa master american express unionpay apple pay paypal google pay